Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma

Record identifier

TN_cdi_proquest_journals_1807087961

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1807087961

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma

Full title

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma

Publisher

England: Nature Publishing Group

Journal title

British journal of cancer, 2016, Vol.115 (3), p.290-296

Record Identifier

TN_cdi_proquest_journals_1807087961

Language

English

Formats

Publication information

Publisher

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_1807087961

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1807087961

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card